Overview

Designed for Confined Surgical Spaces Where Access and Visibility are a Necessity

The LigaSure™ small jaw instrument (LF1212A), working exclusively with the ForceTriad™ energy platform, combines TissueFect™ sensing technology with hand or foot activation and an integrated cutting mechanism to create a multifunctional tissue sealing system that provides consistent, controlled tissue effect.

This instrument is designed for use in open procedures. Procedural applications include:

  • Ear, Nose and Throat (ENT)
  • General
  • Plastic/Reconstructive
  • Urologic
  • Thoracic

The LigaSure™ small jaw instrument is an 18.8 cm (7.4 inch) vessel sealer and divider, designed to be used in confined surgical spaces where access and visibility are a necessity. The instrument has a low temperature profile and seals effectively at a cooler temperature compared to Harmonic FOCUS™*([FOOTNOTE=When compared to the Harmonic FOCUS™* as part of an August 3, 2010, study comparing device temperatures during seal tests on porcine tissue either in-vivo or freshly excised. (Covidien test report R0021935B dated September 14, 2012.)],[ANCHOR=],[LINK=]).

 

Features

The LigaSure™ small jaw instrument:

  • Provides an integrated cutting mechanism independent of sealing, leaving the critical cutting decisions in the hands of the surgeon
  • May reduce the exchange of instruments compared to mechanical ligation
  • Has a low temperature profile and seals effectively at a cooler temperature compared to Harmonic FOCUS™*

LigaSure™ technology confines effect to target tissue with thermal spread ≤ 2mm on average, so you can feel more confident sealing near critical structures and dissecting around vessels.

Ligasure™ technology has been shown to significantly reduce hospital stay and post-operative drainage days compared to conventional techniques when used for axillary breast dissection.([FOOTNOTE=Cortadellas-Rosel T, Córdoba-Cardona O, Espinosa-Bravo M, Mendoza-Santin C, Rodríguez-Fernández J, Esgueva-Colmenarejo A, Alvarez-Vinuesa M, Rubio-Rodríguez IT, Xercavins-Montosa J. Electrothermal bipolar vessel sealing system in axillary dissection: A prospective randomized clinical study. Int J Surg. 2011 Sep 10.],[ANCHOR=],[LINK=]) Additionally, LigaSure™ instruments may be associated with:

  • Reduced procedure time, blood loss and pain compared to conventional techniques([FOOTNOTE=Fareed M et al. Randomized Trial Comparing LigaSure to Closed Ferguson Hemorrhoidectomy. Tech Coloproctol. 2009 Sep; 13(3):243-6.],[ANCHOR=],[LINK=])
  • Reduced operative time, perioperative blood loss, drainage volume and duration, and incidence of seroma or lymphedema([FOOTNOTE=Manouras A, Markogiannakis H, Genetzakis M, Filippakis GM, Lagoudianakis EE, Kafiri G, Filis K, Zografos GC. Modified radical mastectomy with axillary dissection using the electrothermal bipolar vessel sealing system. Arch Surg. 2008 Jun;143(6):575-80.],[ANCHOR=],[LINK=])

Order Information

LigaSure™ Technology – Delivering Performance Beyond Expectations

Across the range of products and procedures, LigaSure™ technology delivers a unique combination of pressure and energy to create a consistent seal with each application.

  • Provides a combination of pressure and energy to create vessel fusion
  • Permanently fuses vessels up to and including 7 mm in diameter and tissue bundles without dissection or isolation
  • Average seal cycle is 2 to 4 seconds, when used with the ForceTriad™ energy platform
  • Seals withstand three times normal systolic blood pressure
  • Feedback-controlled response system automatically discontinues energy delivery when the seal cycle is complete, eliminating the guesswork

LigaSure™ instruments have been found to:

  • Have the highest burst pressure, fastest sealing time and were highest rated overall compared to Gyrus PK™*, Harmonic ACE™* and ENSEAL™*([FOOTNOTE=Lamberton GR, Hsi RS, Jin DH, Lindler TU, JellisonFC, Baldwin DD. Prospective comparison of four laparoscopic vessel ligation devices. J Endourol. 2008;22(10):2307-2312.],[ANCHOR=],[LINK=])
  • Reduce blood loss compared to sutures and clips([FOOTNOTE=Ding Z, Wable G, Rane A. Use of LigaSure bipolar diathermy system in vaginal hysterectomy. J Obstet Gynaecol. 2005;25(1): 49-51.],[ANCHOR=],[LINK=]),([FOOTNOTE=Levy B, Emery L. Randomized trial of suture versus electrosurgical bipolar vessel sealing in vaginal hysterectomy. Obstet Gynecol. 2003;102(1):147-151.],[ANCHOR=],[LINK=])
  • Reduce procedure time compared to sutures6,7
  • Reduce patient length of stay compared to sutures6

Compared to mechanical ligation techniques, LigaSure™ technology has been shown to:

  • Significantly reduce operative blood loss in colorectal, gynecologic and urologic surgery([FOOTNOTE=Targarona, et al. A prospective randomized comparison of conventional electrosurgery, biopolar computer-controlled electrosurgery and ultrasonic dissection. Operative Outcome and Cost analysis. Surgical Innovation. 2005 Dec;12(4):339-344.],[ANCHOR=],[LINK=]),([FOOTNOTE=Manouras, et al. Sutureless open low anterior resection with total mesorectal excision for rectal cancer with the use of the electrothermal bipolar vessel sealing system. 2007. Med Sci Monit; 13(5): CR224-230.],[ANCHOR=],[LINK=]),([FOOTNOTE=Ding Z, et al. Use of LigaSure bipolar diathermy system in vaginal hysterectomy. Journal of Obstetrics Gynaecology. 2005 Jan;25(1):49-51.],[ANCHOR=],[LINK=]),([FOOTNOTE=Levy B, Emery L. Randomized Trial of Suture Versus Electrosurgical Bipolar Vessel Sealing in Vaginal Hysterectomy. Obstetrics and Gynecology. 2003 Jul;102(1):147-151.],[ANCHOR=],[LINK=]),([FOOTNOTE=Tamussino K, et al. Electrosurgical bipolar vessel sealing for radical abdominal hysterectomy. Gynecologic Oncology. 2005 Feb; 96(2):320-322.],[ANCHOR=],[LINK=]),([FOOTNOTE=Leonardo C, et al. Laparoscopic nephrectomy using LigaSure system: preliminary experience. Journal of Endourology. 2005 Oct;19(8):976-8.],[ANCHOR=],[LINK=])
  • Significantly reduce perioperative blood transfusions in gynecologic, urologic and general surgery12,([FOOTNOTE=Daskalopoulos G et al. Electrothermal bipolar coagulation for radical prostatectomies and cystectomies: a preliminary case-controlled study. International Urology and Nephrology. 2004;36(2):181-185.],[ANCHOR=],[LINK=]),([FOOTNOTE=Romano F, et al. Laparoscopic Splenectomy: LigaSure versus EndoGIA: A Comparative Study. J Laparoendoscopic & Adv Surg Techniques. 2007. Vol. 17, No. 6.],[ANCHOR=],[LINK=])
  • Significantly reduce procedure time in colorectal, gynecologic and urologic surgery8,10,11,13,([FOOTNOTE=Cronje HS, et al. Electrosurgical bipolar vessel sealing during vaginal hysterectomy. Int J Gynaecol Obstet. 2005 Dec;91(3):243-5.],[ANCHOR=],[LINK=]),([FOOTNOTE=Metzelder ML, et al. Laparoscopic nephroureterectomy in children: a prospective study on LigaSure versus Clip/Ligation. Eur J Pediatr Surg. 2006 Aug;16(4):241-4.],[ANCHOR=],[LINK=])
  • Significantly reduce length of hospital stay in gynecologic and urologic surgery10,17

Compared to other energy-based modalities, LigaSure™ technology has been shown to:

  • Significantly reduce operative blood loss in colorectal and gynecologic surgery([FOOTNOTE=Araki Y, et al. Clipless hand-assisted laparoscopic total colectomy using LigaSure Atlas. Kurume Medical Journal. 2004;51(2):105-8.],[ANCHOR=],[LINK=]),([FOOTNOTE=Campagnacci R, et al. Electrothermal bipolar vessel sealing device vs. ultrasonic coagulating shears in laparoscopic colectomies: a comparative study. Surg Endosc. 2007 Feb 8.],[ANCHOR=],[LINK=]),([FOOTNOTE=Takada et al. Comparative study of electrothermal bipolar vessel sealer and ultrasonic coagulating shears in laparoscopic colectomy. Surgical Endoscopy. 2005;19:226-228.],[ANCHOR=],[LINK=]),([FOOTNOTE=Demirturk F, et al. Comparison of the use of electrothermal bipolar vessel sealer with harmonic scalpel in total laparoscopic hysterectomy. J Obst Gynaecol Res. 2007; 33 (3):341-345.],[ANCHOR=],[LINK=])
  • Significantly reduce procedure time in colorectal and gynecologic surgery18,21

What is TissueFect™ sensing technology?

TissueFect™ sensing technology is the control system for the ForceTriad™ energy platform, designed to precisely manage energy delivery, creating a range of options for desired tissue effect. TissueFect™ sensing technology monitors changes in tissue impedance 3,333 times a second, and adjusts energy output accordingly to deliver the appropriate amount of energy for the desired tissue effect.

What is LigaSure™ tissue fusion?

LigaSure™ vessel sealing technology has been updated and improved in the ForceTriad™ energy platform, controlled by TissueFect™ sensing technology. LigaSure™ tissue fusion, like LigaSure™ vessel sealing, uses the body’s own collagen and elastin to create a permanent fusion zone. This technology can fuse vessels up to and including 7 mm, lymphatics, tissue bundles and pulmonary vasculature, and has an average seal cycle of two to four seconds in most surgical situations.

Resources